EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia

Clinical trial NCT03519984 · TERMINATED

Trial details

NCT number: NCT03519984
Sponsor: University of Southern California
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Blasts 5 Percent or More of Bone Marrow Nucleated Cells Myelodysplastic/Myeloproliferative Neoplasm Philadelphia Chromosome Positive Recurrent Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Acute Lymphoblastic Leukemia Refractory Acute Myeloid Leukemia Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive Secondary Acute Myeloid Leukemia T Acute Lymphoblastic Leukemia

Start date: 2018-05-09
Primary completion: 2020-11-24
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.